Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,051 signal articles · 245 in last 24h · 119,480 total before filter · latest 39m ago
245last 24h
1499last 7d
251● bullish (7d)
158● bearish (7d)
205publishers
AllMacro288Earnings581M&A107Regulatory20Product13Analyst21
Sentiment:bullishneutralbearishshow all (incl. clickbait)
Lilly Stock Jumps on Earnings Beat as Mounjaro Revenue Nearly Doubles
Barrons.com14d agoneutral
Lilly Stock Jumps on Earnings Beat as Mounjaro Revenue Nearly Doubles

Eli Lilly posted a blockbuster second quarter fueled by continued demand for its portfolio of GLP-1 medications. The world’s biggest drugmaker by market value reported adjusted earnings of $8.38 a share in the period, better than the $6.01 consensus estimate among analysts polled by FactSet. Revenue surged 48% to nearly $23 billion—Wall Street was looking for $20.7 billion.

Bloomberg14d agoneutral
Uber, Wayve Win Licenses for Supervised Robotaxis in London

(Bloomberg) -- Uber Technologies Inc. and UK startup Wayve Technologies Ltd. received permits to launch their robotaxi service in London with a safety driver, getting out ahead of Waymo and Baidu Inc.’s planned rollouts.Most Read from BloombergTrump Says Iran Talks Going Well as Hopes Rise for Hormuz DealSpaceX’s AI Splurge Puts Damper on Debut Earnings After IPOChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersTaco Bell Met With Michigan on Parasite Weeks Before RecallBeer Dynasty

Investing.com14d agoneutral
Disney earnings beat lifts shares despite revenue miss

Investing.com -- Walt Disney Co (NYSE: DIS) shares rose 4.9% premarket after the entertainment giant reported third-quarter adjusted earnings that exceeded Wall Street expectations, though revenue came in slightly below estimates.

Bloomberg14d agoneutral
Carry Trade Is Powering On as Investors Sidestep Yen’s Gains

(Bloomberg) -- Emerging-market carry trades, some of this year’s most popular foreign-exchange bets, are showing resilience even after joint US-Japan currency intervention dented the appeal of this yen-funded strategy.Most Read from BloombergTrump Says Iran Talks Going Well as Hopes Rise for Hormuz DealChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersSpaceX’s AI Splurge Puts a Damper on Debut Earnings After IPOBeer Dynasty Families Sell €731 Million Stake in AB InBevTaco Bell Met W

Netlist, Samsung settle patent disputes in new five-year memory deal
Reuters14d agoneutral
Netlist, Samsung settle patent disputes in new five-year memory deal

Netlist has struck a five-year deal to license its memory chip patents to Samsung Electronics, ‌it said on Wednesday, gaining access to the ‌South Korean firm's products and ending years of legal disputes between the companies. Here ​are some details: • Netlist develops advanced memory and storage technologies, including server memory and high-bandwidth memory technologies used in AI computing. Samsung will receive access to Netlist's patent portfolio, including its ‌server dual in-line memory ⁠module and high-bandwidth memory technologies used in AI servers and high-performance computing.

Canada's Shopify forecasts revenue above estimates, shares surge
Reuters14d agobullish
Canada's Shopify forecasts revenue above estimates, shares surge

Canada's Shopify projected current-quarter revenue growth above Wall Street estimates on Wednesday, signaling the company's AI efforts were drawing more merchants ‌to its suite of e-commerce services, sending its U.S.-listed shares up 26% ‌premarket. The company's solid outlook and a second-quarter revenue beat are set to quell investor concerns about growing ​competition from new AI tools targeting small businesses that have dented Shopify's shares. If premarket gains hold, Shopify shares are set to recoup all losses this year.

Eli Lilly raises annual revenue forecast as obesity, diabetes drug demand stay strong
Reuters14d agobullish
Eli Lilly raises annual revenue forecast as obesity, diabetes drug demand stay strong

Aug 5 () - Eli Lilly and Co raised ‌its full-year revenue ‌forecast on Wednesday, banking ​on sustained demand for its blockbuster GLP-1 weight-loss and diabetes drugs. The ‌move comes ⁠less than a day after rival ⁠Novo Nordisk also hiked its full-year profit ​and sales ​forecast, ​banking on ‌its oral Wegovy pill to help claw back lost ground from Lilly in the lucrative ‌obesity market.

AMD’s Data-Center Strength
The Wall Street Journal14d agoneutral
AMD’s Data-Center Strength

$1.4 trillion That's how big the market for data center AI accelerators—microchips designed to process tasks like machine learning—will be by 2030, according to Advanced Micro Devices CEO Lisa Su. During yesterday's earnings call, she said the data-center market is expanding “far more rapidly than we projected just six months ago," boosting her company's growth prospects.

NRG Energy Q2 Earnings Call Highlights
MarketBeat14d agoneutral
NRG Energy Q2 Earnings Call Highlights

NRG Energy (NYSE:NRG) reported second-quarter 2026 adjusted EBITDA of $1.2 billion, up 34% from a year earlier, while outlining plans for a 1.2-gigawatt Texas power plant intended to support a cloud and artificial intelligence hyperscaler’s data center load. President and Chief Executive Officer Ro